EUR 19.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -39.89 Thousand EUR | 85.08% |
2022 | -267.47 Thousand EUR | 0.0% |
2020 | 3861.00 EUR | -98.56% |
2019 | 268.18 Thousand EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2021 Q1 | 789.43 Thousand EUR | 0.0% |
2020 FY | - EUR | -98.56% |
2019 FY | - EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Crossject Société Anonyme | -7.29 Million EUR | 99.453% |
Safe Orthopaedics SA | -5.62 Million EUR | 99.291% |
Spineway SA | -4.79 Million EUR | 99.167% |
Amplitude Surgical SA | 24.72 Million EUR | 100.161% |
Sartorius Stedim Biotech S.A. | 777.2 Million EUR | 100.005% |
EssilorLuxottica Société anonyme | 6.18 Billion EUR | 100.001% |